Treatment preferences of patients with relapsed or refractory multiple myeloma in the United States, United Kingdom, Italy, Germany, France, and Spain: results from a discrete choice experiment

Treatment preferences of patients with relapsed or refractory multiple myeloma in the United States, United Kingdom, Italy, Germany, France, and Spain: results from a discrete choice experiment

IntroductionNewer treatment options for relapsed/refractory multiple myeloma (RRMM) with efficacy and safety profiles that differ from traditional therapies have facilitated personalized management strategies to optimize patient outcomes. In the context of such personalized management, understanding...

Full description

Bibliographic Details
Main Authors: Caitlin Thomas, Sikander Ailawadhi, Rakesh Popat, David Kleinman, Melissa M. Ross, Boris Gorsh, Sarah Mulnick, Alicia O’Neill, Prani Paka, Maya Hanna, Nicolas Krucien, Alexa Molinari, Heather L. Gelhorn, Sue Perera
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Medicine
Subjects:
benefit–risk
discrete choice experiment
multiple myeloma
patient preferences
trade-offs
treatment attributes
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2023.1271657/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2023.1271657/full

Similar Items